Long-lasting remission in a metastatic hepatocellular carcinoma patient after combined regorafenib therapy and surgery

por Goio, Elisabetta, Ielasi, Luca, Benevento, Francesca, Renzulli, Matteo, Tovoli, Francesco
Publicado 2020

Systemic treatments for hepatocellular carcinoma: challenges and future perspectives

por Tovoli, Francesco, Negrini, Giulia, Benevento, Francesca, Faggiano, Chiara, Goio, Elisabetta, Granito, Alessandro
Publicado 2018

Regorafenib Combined with Other Systemic Therapies: Exploring Promising Therapeutic Combinations in HCC

por Granito, Alessandro, Marinelli, Sara, Forgione, Antonella, Renzulli, Matteo, Benevento, Francesca, Piscaglia, Fabio, Tovoli, Francesco
Publicado 2021

Experience with regorafenib in the treatment of hepatocellular carcinoma

por Granito, Alessandro, Forgione, Antonella, Marinelli, Sara, Renzulli, Matteo, Ielasi, Luca, Sansone, Vito, Benevento, Francesca, Piscaglia, Fabio, Tovoli, Francesco
Publicado 2021

Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients

por Benevento, Francesca, Pecorelli, Anna, Stefanescu, Horia, Sparchez, Zeno, Vukotic, Ranka, Pettinari, Irene, Grigoras, Crina-Anca, Tovoli, Francesco, Ravaioli, Federico, Stefanini, Bernardo, Andreone, Pietro, Piscaglia, Fabio
Publicado 2023

Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international study

por Fessas, Petros, Kaseb, Ahmed, Wang, Yinghong, Saeed, Anwaar, Szafron, David, Jun, Tomi, Dharmapuri, Sirish, Rafeh Naqash, Abdul, Muzaffar, Mahvish, Navaid, Musharraf, Khan, Uqba, Lee, ChiehJu, Bulumulle, Anushi, Yu, Bo, Paul, Sonal, Nimkar, Neil, Bettinger, Dominik, Benevento, Francesca, Hildebrand, Hannah, Pressiani, Tiziana, Abugabal, Yehia I, Personeni, Nicola, Huang, Yi-Hsiang, Rimassa, Lorenza, Ang, Celina, Marron, Thomas, Pinato, David J
Publicado 2020